|
December 23 2003
Lek Successfully Defends Patent for Synthesis of Omeprazole
December 03 2003
Innovator of the Year 2002
November 25 2003
Path Paved for Lek to Continue Sales of Co-Amoxiclav
October 15 2003
Lek's medicines will continue to be available without copayment
September 25 2003
Bayer AG and Lek d.d. signed a Share Purchase Agreement on transferring of Lek's ownership share in Bayer Pharma d.o.o. to Bayer AG
September 03 2003
Change of the company name of Argon SA
August 27 2003
President of the Polish Government Mr Leszek Miller
August 21 2003
Lek's Omeprazole in the US Market
August 05 2003
Resolutions of the 19th General Meeting of Lek d.d.
July 18 2003
Duke of the Polish Lodz region came to visit Slovenia
July 01 2003
Supervisory Board Meeting
June 30 2003
DEAR SHAREHOLDERS
June 16 2003
Lek's investment in Stryków in full swing
April 14 2003
Recall of one batch of Lekadol tablets, 20 x 500 mg
April 11 2003
When used appropriately, Dermo spray N does not cause the presence of chloramphenicol in milk
March 28 2003
1st Meeting of the Newly Appointed Supervisory Board
March 19 2003
Summary of audited unconsolidated accounts for the financial year 2002
February 04 2003
Withdrawal of Lek shares
February 04 2003
Lek obtains marketing authorization for omeprazol
January 21 2003
Boxes of Modolex Drug Contain the Correct Active Ingredient
January 20 2003
Lek Shareholders adopted the Resolutions proposed
January 06 2003
Lek Enters the U.S. Market with Co-Amoxiclav
 |
